MS Study

Project uploaded by:	Swasti
Project ID:	IMP_100040
Title:	Kingdom-specific lipid unsaturation calibrates sequence evolution in membrane arm subunits of eukaryotic respiratory complexes
Project Description:	Sequence evolution of protein complexes (PCs) is constrained by protein-protein interactions (PPIs). PPI-interfaces are predominantly conserved and hotspots for disease-related mutations. How do lipid-protein interactions (LPIs) constrain sequence evolution of membrane-PCs? We explore Respiratory Complexes (RCs) as a case study as these allow to compare sequence evolution in subunits exposed to both lipids in inner-mitochondrial membrane (IMM) and lipid-free aqueous matrix. We find that lipid-exposed surfaces of the IMM-subunits but not of the matrix subunits are populated with non-PPI disease-causing mutations signifying LPIs in stabilizing RCs. Further, IMM-subunits including their exposed surfaces show high intra-kingdom sequence conservation but remarkably diverge beyond. Molecular Dynamics simulation suggests contrasting LPIs of structurally superimposable but sequence-wise diverged IMM-exposed helices of Complex I (CI) subunit Ndufa1 from human and Arabidopsis depending on kingdom-specific unsaturation of cardiolipin fatty acyl chains. in cellulo assays consolidate inter-kingdom incompatibility of Ndufa1-helices due to the lipid-exposed amino acids. Plant-specific unsaturated fatty acids in human cells also trigger CI-instability. Taken together, we posit that altered LPIs calibrate sequence evolution at the IMM-arms of eukaryotic RCs.
Research Area:	Biological Sciences
Funding Source:	NIH grant, U2C- DK119886
Project Contributors:	Pooja Gupta, Sristi Chakroborty, Arun K. Rathod, K. Ranjith Kumar, Shreya Bhat, Suparna Ghosh, Pallavi Rao T, Kameshwari Yele, Raman Bakthisaran, R. Nagaraj, Moutusi Manna & Swasti Raychaudhuri

Study uploaded by:	Swasti
Study ID:	IMS_100035
Title:	Kingdom-specific lipid unsaturation calibrates sequence evolution in membrane arm subunits of eukaryotic respiratory complexes
Summary:	Sequence evolution of protein complexes (PCs) is constrained by protein-protein interactions (PPIs). PPI-interfaces are predominantly conserved and hotspots for disease-related mutations. How do lipid-protein interactions (LPIs) constrain sequence evolution of membrane-PCs? We explore Respiratory Complexes (RCs) as a case study as these allow to compare sequence evolution in subunits exposed to both lipids in inner-mitochondrial membrane (IMM) and lipid-free aqueous matrix. We find that lipid-exposed surfaces of the IMM-subunits but not of the matrix subunits are populated with non-PPI disease-causing mutations signifying LPIs in stabilizing RCs. Further, IMM-subunits including their exposed surfaces show high intra-kingdom sequence conservation but remarkably diverge beyond. Molecular Dynamics simulation suggests contrasting LPIs of structurally superimposable but sequence-wise diverged IMM-exposed helices of Complex I (CI) subunit Ndufa1 from human and Arabidopsis depending on kingdom-specific unsaturation of cardiolipin fatty acyl chains. in cellulo assays consolidate inter-kingdom incompatibility of Ndufa1-helices due to the lipid-exposed amino acids. Plant-specific unsaturated fatty acids in human cells also trigger CI-instability. Taken together, we posit that altered LPIs calibrate sequence evolution at the IMM-arms of eukaryotic RCs.
Publication:	https://www.nature.com/articles/s41467-025-57295-7
Release Date:	July 8, 2025
Study Type:	Mass Spectrometry (MS)
Data Type:	Untargeted
IEC/IBSC Approval Number :

Sr.No	Sample ID	Sample Name	Organism	Source	Sample Preparation Protocol	Sample Type	Experimental Condition	Time of treatment	Variant/Variety	Gender	Age	Replicates	Storage Conditions	Extraction Protocol	Number of files per sample
1	IMSM_101905	Experimental Blank-1	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -80°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
2	IMSM_101918	Experimental Blank-2	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -80°C until further use.	LC buffer	BLank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
3	IMSM_101919	Experimental Blank-3	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -81°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
4	IMSM_101920	Experimental Blank-4	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -82°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
5	IMSM_101921	Experimental Blank-5	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -83°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
6	IMSM_101922	Experimental Blank-6	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -84°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
7	IMSM_101923	Experimental Blank-7	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -85°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
8	IMSM_101924	Experimental Blank-8	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -86°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
9	IMSM_101925	Experimental Blank-9	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -87°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
10	IMSM_101926	Experimental Blank-10	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -88°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
11	IMSM_101927	Experimental Blank-11	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -89°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
12	IMSM_101928	Experimental Blank-12	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -90°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
13	IMSM_101929	Experimental Blank-13	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -91°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
14	IMSM_101930	Experimental Blank-14	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -92°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
15	IMSM_101931	Experimental Blank-15	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -93°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
16	IMSM_101932	Experimental Blank-16	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -94°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
17	IMSM_101933	Experimental Blank-17	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -95°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
18	IMSM_101934	Experimental Blank-18	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -96°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
19	IMSM_101935	Experimental Blank-19	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -97°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
20	IMSM_101936	Experimental Blank-20	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -98°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
21	IMSM_101937	Experimental Blank-21	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -99°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
22	IMSM_101938	Experimental Blank-22	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -100°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
23	IMSM_101939	Experimental Blank-23	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -101°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
24	IMSM_101940	Experimental Blank-24	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -102°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
25	IMSM_101941	Experimental Blank-25	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -103°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
26	IMSM_101942	Experimental Blank-26	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -104°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
27	IMSM_101943	Experimental Blank-27	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -105°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
28	IMSM_101944	Experimental Blank-28	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -106°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
29	IMSM_101945	Experimental Blank-29	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -107°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
30	IMSM_101946	Experimental Blank-30	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -108°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
31	IMSM_101947	Experimental Blank-31	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -109°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
32	IMSM_101948	Experimental Blank-32	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -110°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
33	IMSM_101949	Experimental Blank-33	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -111°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
34	IMSM_101950	Experimental Blank-34	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -112°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
35	IMSM_101951	Experimental Blank-35	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -113°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
36	IMSM_101952	Experimental Blank-36	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -114°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
37	IMSM_101953	Experimental Blank-37	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -115°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
38	IMSM_101954	Experimental Blank-38	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -116°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
39	IMSM_101955	Experimental Blank-40	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -117°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
40	IMSM_101956	Experimental Blank-41	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -118°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
41	IMSM_101957	Experimental Blank-42	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -119°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
42	IMSM_101958	Experimental Blank-43	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -120°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
43	IMSM_101959	Experimental Blank-44	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -121°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
44	IMSM_101960	Experimental Blank-45	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -122°C until further use.	LC buffer	Blank	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
45	IMSM_101961	HEK293T-BSA-R1	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -123°C until further use.	HEK293T cultured cells	Control	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
46	IMSM_101962	HEK293T-BSA-R2	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -124°C until further use.	HEK293T cultured cells	Control	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
47	IMSM_101963	HEK293T-BSA-R3	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -125°C until further use.	HEK293T cultured cells	Control	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
48	IMSM_101964	HEK293T-BSA-R4	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -126°C until further use.	HEK293T cultured cells	Control	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
49	IMSM_101965	HEK293T-BSA-R5	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -127°C until further use.	HEK293T cultured cells	Control	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
50	IMSM_101966	HEK293T-BSA-R6	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -128°C until further use.	HEK293T cultured cells	Control	0 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
51	IMSM_101967	HEK293T-18 2-treated-R1	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -129°C until further use.	HEK293T cultured cells	Linoleic acid treatment	72 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
52	IMSM_101968	HEK293T-18 2-treated-R2	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -130°C until further use.	HEK293T cultured cells	Linoleic acid treatment	72 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
53	IMSM_101969	HEK293T-18 2-treated-R3	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -131°C until further use.	HEK293T cultured cells	Linoleic acid treatment	72 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
54	IMSM_101970	HEK293T-18 2-treated-R4	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -132°C until further use.	HEK293T cultured cells	Linoleic acid treatment	72 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
55	IMSM_101971	HEK293T-18 2-treated-R5	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -133°C until further use.	HEK293T cultured cells	Linoleic acid treatment	72 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
56	IMSM_101972	HEK293T-18 2-treated-R6	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -134°C until further use.	HEK293T cultured cells	Linoleic acid treatment	72 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
57	IMSM_101973	HEK293T-18 3-treated-R1	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -135°C until further use.	HEK293T cultured cells	Linoleic acid treatment	72 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
58	IMSM_101974	HEK293T-18 3-treated-R2	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -136°C until further use.	HEK293T cultured cells	Linoleic acid treatment	72 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
59	IMSM_101975	HEK293T-18 3-treated-R3	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -137°C until further use.	HEK293T cultured cells	Linoleic acid treatment	72 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
60	IMSM_101976	HEK293T-18 3-treated-R4	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -138°C until further use.	HEK293T cultured cells	Linoleic acid treatment	72 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
61	IMSM_101977	HEK293T-18 3-treated-R5	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -139°C until further use.	HEK293T cultured cells	Linoleic acid treatment	72 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2
62	IMSM_101978	HEK293T-18 3-treated-R6	Homo sapiens	HEK293T cultured cells	150 mg of mitochondria isolated from BSA, linoleic and linolenic acid treated Hs-A1-EGFP cells were resuspended in 250 μl of PBS. Lipids were isolated by modified Folch method. Briefly 750 μl of 2:1 (v/v) chloroform (CHCl3): methanol (MeOH) containing CL 56:0 (14:0)4 as an internal standard (IS) was added to the mitochondrial fraction and vortexed thoroughly. Phase separation was achieved by centrifugation at 2000 g for 5 mins. The organic phase was collected in a fresh glass vial. Re-extraction was performed from the aqueous phase by adding 500 μl of chloroform, 10% (v/v) formic acid, followed by vortex and centrifuge. The organic phase was pooled and dried under the stream of nitrogen gas. Isolated mitochondria and dried lipids were stored in -140°C until further use.	HEK293T cultured cells	Linoleic acid treatment	72 hours	NA	NA	NA	NA	Processing Storage Conditions 4℃ and Extract Storage -80℃	NA	2

Sr.No	MS Exp ID	Sample Name/ID	Mass Spectrometer Type	MS Instrument Name	MS Instrument type	MS Ionization Method	Ion Mode/Scan Polarity	Data Transformation (Software/s Used)
1	IME_101145	Experimental Blank-1 / IMSM_101905	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
2	IME_101146	Experimental Blank-1 / IMSM_101905	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
3	IME_101147	Experimental Blank-2 / IMSM_101918	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
4	IME_101148	Experimental Blank-2 / IMSM_101918	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
5	IME_101149	Experimental Blank-3 / IMSM_101919	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
6	IME_101150	Experimental Blank-3 / IMSM_101919	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
7	IME_101151	Experimental Blank-4 / IMSM_101920	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
8	IME_101152	Experimental Blank-4 / IMSM_101920	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
9	IME_101153	Experimental Blank-5 / IMSM_101921	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
10	IME_101154	Experimental Blank-5 / IMSM_101921	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
11	IME_101155	Experimental Blank-6 / IMSM_101922	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
12	IME_101156	Experimental Blank-6 / IMSM_101922	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
13	IME_101157	Experimental Blank-7 / IMSM_101923	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
14	IME_101158	Experimental Blank-7 / IMSM_101923	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
15	IME_101159	Experimental Blank-8 / IMSM_101924	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
16	IME_101160	Experimental Blank-8 / IMSM_101924	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
17	IME_101161	Experimental Blank-9 / IMSM_101925	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
18	IME_101162	Experimental Blank-9 / IMSM_101925	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
19	IME_101163	Experimental Blank-10 / IMSM_101926	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
20	IME_101164	Experimental Blank-10 / IMSM_101926	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
21	IME_101165	Experimental Blank-11 / IMSM_101927	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
22	IME_101166	Experimental Blank-11 / IMSM_101927	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
23	IME_101167	Experimental Blank-12 / IMSM_101928	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
24	IME_101168	Experimental Blank-12 / IMSM_101928	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
25	IME_101169	Experimental Blank-13 / IMSM_101929	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
26	IME_101170	Experimental Blank-13 / IMSM_101929	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
27	IME_101171	Experimental Blank-14 / IMSM_101930	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
28	IME_101172	Experimental Blank-14 / IMSM_101930	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
29	IME_101173	Experimental Blank-15 / IMSM_101931	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
30	IME_101174	Experimental Blank-15 / IMSM_101931	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
31	IME_101175	Experimental Blank-16 / IMSM_101932	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
32	IME_101176	Experimental Blank-16 / IMSM_101932	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
33	IME_101177	Experimental Blank-17 / IMSM_101933	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
34	IME_101178	Experimental Blank-17 / IMSM_101933	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
35	IME_101179	Experimental Blank-18 / IMSM_101934	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
36	IME_101180	Experimental Blank-18 / IMSM_101934	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
37	IME_101181	Experimental Blank-19 / IMSM_101935	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
38	IME_101182	Experimental Blank-19 / IMSM_101935	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
39	IME_101183	Experimental Blank-20 / IMSM_101936	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
40	IME_101184	Experimental Blank-20 / IMSM_101936	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
41	IME_101185	Experimental Blank-21 / IMSM_101937	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
42	IME_101186	Experimental Blank-21 / IMSM_101937	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
43	IME_101187	Experimental Blank-22 / IMSM_101938	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
44	IME_101188	Experimental Blank-22 / IMSM_101938	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
45	IME_101189	Experimental Blank-23 / IMSM_101939	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
46	IME_101190	Experimental Blank-23 / IMSM_101939	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
47	IME_101191	Experimental Blank-24 / IMSM_101940	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
48	IME_101192	Experimental Blank-24 / IMSM_101940	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
49	IME_101193	Experimental Blank-25 / IMSM_101941	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
50	IME_101194	Experimental Blank-25 / IMSM_101941	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
51	IME_101195	Experimental Blank-26 / IMSM_101942	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
52	IME_101196	Experimental Blank-26 / IMSM_101942	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
53	IME_101197	Experimental Blank-27 / IMSM_101943	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
54	IME_101198	Experimental Blank-27 / IMSM_101943	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
55	IME_101199	Experimental Blank-28 / IMSM_101944	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
56	IME_101200	Experimental Blank-28 / IMSM_101944	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
57	IME_101201	Experimental Blank-29 / IMSM_101945	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
58	IME_101202	Experimental Blank-29 / IMSM_101945	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
59	IME_101203	Experimental Blank-30 / IMSM_101946	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
60	IME_101204	Experimental Blank-30 / IMSM_101946	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
61	IME_101205	Experimental Blank-31 / IMSM_101947	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
62	IME_101206	Experimental Blank-31 / IMSM_101947	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
63	IME_101207	Experimental Blank-32 / IMSM_101948	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
64	IME_101208	Experimental Blank-32 / IMSM_101948	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
65	IME_101209	Experimental Blank-33 / IMSM_101949	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
66	IME_101210	Experimental Blank-33 / IMSM_101949	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
67	IME_101211	Experimental Blank-34 / IMSM_101950	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
68	IME_101212	Experimental Blank-34 / IMSM_101950	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
69	IME_101213	Experimental Blank-35 / IMSM_101951	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
70	IME_101214	Experimental Blank-35 / IMSM_101951	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
71	IME_101215	Experimental Blank-36 / IMSM_101952	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
72	IME_101216	Experimental Blank-36 / IMSM_101952	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
73	IME_101217	Experimental Blank-37 / IMSM_101953	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
74	IME_101218	Experimental Blank-37 / IMSM_101953	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
75	IME_101219	Experimental Blank-38 / IMSM_101954	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
76	IME_101220	Experimental Blank-38 / IMSM_101954	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
77	IME_101221	Experimental Blank-40 / IMSM_101955	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
78	IME_101222	Experimental Blank-40 / IMSM_101955	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
79	IME_101223	Experimental Blank-41 / IMSM_101956	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
80	IME_101224	Experimental Blank-41 / IMSM_101956	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
81	IME_101225	Experimental Blank-42 / IMSM_101957	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
82	IME_101226	Experimental Blank-42 / IMSM_101957	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
83	IME_101227	Experimental Blank-43 / IMSM_101958	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
84	IME_101228	Experimental Blank-43 / IMSM_101958	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
85	IME_101229	Experimental Blank-44 / IMSM_101959	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
86	IME_101230	Experimental Blank-44 / IMSM_101959	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
87	IME_101231	Experimental Blank-45 / IMSM_101960	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
88	IME_101232	Experimental Blank-45 / IMSM_101960	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
89	IME_101233	HEK293T-BSA-R1 / IMSM_101961	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
90	IME_101234	HEK293T-BSA-R1 / IMSM_101961	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
91	IME_101235	HEK293T-BSA-R2 / IMSM_101962	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
92	IME_101236	HEK293T-BSA-R2 / IMSM_101962	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
93	IME_101237	HEK293T-BSA-R3 / IMSM_101963	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
94	IME_101238	HEK293T-BSA-R3 / IMSM_101963	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
95	IME_101239	HEK293T-BSA-R4 / IMSM_101964	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
96	IME_101240	HEK293T-BSA-R4 / IMSM_101964	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
97	IME_101241	HEK293T-BSA-R5 / IMSM_101965	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
98	IME_101242	HEK293T-BSA-R5 / IMSM_101965	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
99	IME_101243	HEK293T-BSA-R6 / IMSM_101966	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
100	IME_101244	HEK293T-BSA-R6 / IMSM_101966	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
101	IME_101245	HEK293T-18 2-treated-R1 / IMSM_101967	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
102	IME_101246	HEK293T-18 2-treated-R1 / IMSM_101967	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
103	IME_101247	HEK293T-18 2-treated-R2 / IMSM_101968	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
104	IME_101248	HEK293T-18 2-treated-R2 / IMSM_101968	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
105	IME_101249	HEK293T-18 2-treated-R3 / IMSM_101969	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
106	IME_101250	HEK293T-18 2-treated-R3 / IMSM_101969	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
107	IME_101251	HEK293T-18 2-treated-R4 / IMSM_101970	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
108	IME_101252	HEK293T-18 2-treated-R4 / IMSM_101970	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
109	IME_101253	HEK293T-18 2-treated-R5 / IMSM_101971	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
110	IME_101254	HEK293T-18 2-treated-R5 / IMSM_101971	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
111	IME_101255	HEK293T-18 2-treated-R6 / IMSM_101972	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
112	IME_101256	HEK293T-18 2-treated-R6 / IMSM_101972	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
113	IME_101257	HEK293T-18 3-treated-R1 / IMSM_101973	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
114	IME_101258	HEK293T-18 3-treated-R1 / IMSM_101973	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
115	IME_101259	HEK293T-18 3-treated-R2 / IMSM_101974	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
116	IME_101260	HEK293T-18 3-treated-R2 / IMSM_101974	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
117	IME_101261	HEK293T-18 3-treated-R3 / IMSM_101975	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
118	IME_101262	HEK293T-18 3-treated-R3 / IMSM_101975	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
119	IME_101263	HEK293T-18 3-treated-R4 / IMSM_101976	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
120	IME_101264	HEK293T-18 3-treated-R4 / IMSM_101976	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
121	IME_101265	HEK293T-18 3-treated-R5 / IMSM_101977	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
122	IME_101266	HEK293T-18 3-treated-R5 / IMSM_101977	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
123	IME_101267	HEK293T-18 3-treated-R6 / IMSM_101978	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43
124	IME_101268	HEK293T-18 3-treated-R6 / IMSM_101978	LCMS (Liquid Chromatography- Mass Spectrometry)	ABI Sciex 6500 QTrap\|MS_1002581	Triple quadrupole	Electrospray Ionization - ESI	Negative	Analytics version 3.3.1.43

Sr.No	First name	Last name	Email	Organization	Designation
1	Swasti	Raychaudhuri	rcswasti@ccmb.res.in	CSIR-Centre for Cellular & Molecular Biology	principal_investigator

Sr.No	ftprun ID	MS Exp ID	MS Data Files
1	IMR_101749	IME_101145	Blank-1.wiff
2	IMR_101750	IME_101146	Blank-1.wiff.scan
3	IMR_101751	IME_101147	Blank-2.wiff
4	IMR_101752	IME_101148	Blank-2.wiff.scan
5	IMR_101753	IME_101149	Blank-3.wiff
6	IMR_101754	IME_101150	Blank-3.wiff.scan
7	IMR_101755	IME_101151	Blank-4.wiff
8	IMR_101756	IME_101152	Blank-4.wiff.scan
9	IMR_101757	IME_101153	Blank-5.wiff
10	IMR_101758	IME_101154	Blank-5.wiff.scan
11	IMR_101759	IME_101155	Blank-6.wiff
12	IMR_101760	IME_101156	Blank-6.wiff.scan
13	IMR_101761	IME_101157	Blank-7.wiff
14	IMR_101762	IME_101158	Blank-7.wiff.scan
15	IMR_101763	IME_101159	Blank-8.wiff
16	IMR_101764	IME_101160	Blank-8.wiff.scan
17	IMR_101765	IME_101161	Blank-9.wiff
18	IMR_101766	IME_101162	Blank-9.wiff.scan
19	IMR_101767	IME_101163	Blank-10.wiff
20	IMR_101768	IME_101164	Blank-10.wiff.scan
21	IMR_101769	IME_101165	Blank-11.wiff
22	IMR_101770	IME_101166	Blank-11.wiff.scan
23	IMR_101771	IME_101167	Blank-12.wiff
24	IMR_101772	IME_101168	Blank-12.wiff.scan
25	IMR_101773	IME_101169	Blank-13.wiff
26	IMR_101774	IME_101170	Blank-13.wiff.scan
27	IMR_101775	IME_101171	Blank-14.wiff
28	IMR_101776	IME_101172	Blank-14.wiff.scan
29	IMR_101777	IME_101173	Blank-15.wiff
30	IMR_101778	IME_101174	Blank-15.wiff.scan
31	IMR_101779	IME_101175	Blank-16.wiff
32	IMR_101780	IME_101176	Blank-16.wiff.scan
33	IMR_101781	IME_101177	Blank-17.wiff
34	IMR_101782	IME_101178	Blank-17.wiff.scan
35	IMR_101783	IME_101179	Blank-18.wiff
36	IMR_101784	IME_101180	Blank-18.wiff.scan
37	IMR_101785	IME_101181	Blank-19.wiff
38	IMR_101786	IME_101182	Blank-19.wiff.scan
39	IMR_101787	IME_101183	Blank-20.wiff
40	IMR_101788	IME_101184	Blank-20.wiff.scan
41	IMR_101789	IME_101185	Blank-21.wiff
42	IMR_101790	IME_101186	Blank-21.wiff.scan
43	IMR_101791	IME_101187	Blank-22.wiff
44	IMR_101792	IME_101188	Blank-22.wiff.scan
45	IMR_101793	IME_101189	Blank-23.wiff
46	IMR_101794	IME_101190	Blank-23.wiff.scan
47	IMR_101795	IME_101191	Blank-24.wiff
48	IMR_101796	IME_101192	Blank-24.wiff.scan
49	IMR_101797	IME_101193	Blank-25.wiff
50	IMR_101798	IME_101194	Blank-25.wiff.scan
51	IMR_101799	IME_101195	Blank-26.wiff
52	IMR_101800	IME_101196	Blank-26.wiff.scan
53	IMR_101801	IME_101197	Blank-27.wiff
54	IMR_101802	IME_101198	Blank-27.wiff.scan
55	IMR_101803	IME_101199	Blank-28.wiff
56	IMR_101804	IME_101200	Blank-28.wiff.scan
57	IMR_101805	IME_101201	Blank-29.wiff
58	IMR_101806	IME_101202	Blank-29.wiff.scan
59	IMR_101807	IME_101203	Blank-30.wiff
60	IMR_101808	IME_101204	Blank-30.wiff.scan
61	IMR_101809	IME_101205	Blank-31.wiff
62	IMR_101810	IME_101206	Blank-31.wiff.scan
63	IMR_101811	IME_101207	Blank-32.wiff
64	IMR_101812	IME_101208	Blank-32.wiff.scan
65	IMR_101813	IME_101209	Blank-33.wiff
66	IMR_101814	IME_101210	Blank-33.wiff.scan
67	IMR_101815	IME_101211	Blank-34.wiff
68	IMR_101816	IME_101212	Blank-34.wiff.scan
69	IMR_101817	IME_101213	Blank-35.wiff
70	IMR_101818	IME_101214	Blank-35.wiff.scan
71	IMR_101819	IME_101215	Blank-36.wiff
72	IMR_101820	IME_101216	Blank-36.wiff.scan
73	IMR_101821	IME_101217	Blank-37.wiff
74	IMR_101822	IME_101218	Blank-37.wiff.scan
75	IMR_101823	IME_101219	Blank-38.wiff
76	IMR_101824	IME_101220	Blank-38.wiff.scan
77	IMR_101825	IME_101221	Blank-39.wiff
78	IMR_101826	IME_101222	Blank-39.wiff.scan
79	IMR_101827	IME_101223	Blank-40.wiff
80	IMR_101828	IME_101224	Blank-40.wiff.scan
81	IMR_101829	IME_101225	Blank-41.wiff
82	IMR_101830	IME_101226	Blank-41.wiff.scan
83	IMR_101831	IME_101227	Blank-42.wiff
84	IMR_101832	IME_101228	Blank-42.wiff.scan
85	IMR_101833	IME_101229	Blank-43.wiff
86	IMR_101834	IME_101230	Blank-43.wiff.scan
87	IMR_101835	IME_101231	Blank-44.wiff
88	IMR_101836	IME_101232	Blank-44.wiff.scan
89	IMR_101837	IME_101233	HEK-BSA-R1.wiff
90	IMR_101838	IME_101234	HEK-BSA-R1.wiff.scan
91	IMR_101839	IME_101235	HEK-BSA-R2.wiff
92	IMR_101840	IME_101236	HEK-BSA-R2.wiff.scan
93	IMR_101841	IME_101237	HEK-BSA-R3.wiff
94	IMR_101842	IME_101238	HEK-BSA-R3.wiff.scan
95	IMR_101843	IME_101239	HEK-BSA-R4.wiff
96	IMR_101844	IME_101240	HEK-BSA-R4.wiff.scan
97	IMR_101845	IME_101241	HEK-BSA-R5.wiff
98	IMR_101846	IME_101242	HEK-BSA-R5.wiff.scan
99	IMR_101847	IME_101243	HEK-BSA-R6.wiff
100	IMR_101848	IME_101244	HEK-BSA-R6.wiff.scan
101	IMR_101849	IME_101245	HEK-18-2-R1.wiff
102	IMR_101850	IME_101246	HEK-18-2-R1.wiff.scan
103	IMR_101851	IME_101247	HEK-18-3-R1.wiff
104	IMR_101852	IME_101248	HEK-18-3-R1.wiff.scan
105	IMR_101853	IME_101249	HEK-18-2-R2.wiff
106	IMR_101854	IME_101250	HEK-18-2-R2.wiff.scan
107	IMR_101855	IME_101251	HEK-18-3-R2.wiff
108	IMR_101856	IME_101252	HEK-18-3-R2.wiff.scan
109	IMR_101857	IME_101253	HEK-18-2-R3.wiff
110	IMR_101858	IME_101254	HEK-18-2-R3.wiff.scan
111	IMR_101859	IME_101255	HEK-18-3-R3.wiff
112	IMR_101860	IME_101256	HEK-18-3-R3.wiff.scan
113	IMR_101861	IME_101257	HEK-18-2-R4.wiff
114	IMR_101862	IME_101258	HEK-18-2-R4.wiff.scan
115	IMR_101863	IME_101259	HEK-18-3-R4.wiff
116	IMR_101864	IME_101260	HEK-18-3-R4.wiff.scan
117	IMR_101865	IME_101261	HEK-18-2-R5.wiff
118	IMR_101866	IME_101262	HEK-18-2-R5.wiff.scan
119	IMR_101867	IME_101263	HEK-18-3-R5.wiff
120	IMR_101868	IME_101264	HEK-18-3-R5.wiff.scan
121	IMR_101869	IME_101265	HEK-18-2-R6.wiff
122	IMR_101870	IME_101266	HEK-18-2-R6.wiff.scan
123	IMR_101871	IME_101267	HEK-18-3-R6.wiff
124	IMR_101872	IME_101268	HEK-18-3-R6.wiff.scan

MS Study

Project

Study

Sample (Total Count:62)

Mass Spectrometry

Author List

File Details